Functional analyses performed by Hu et al. [36] in CRC demonstrated that CD47 (a molecule which plays a crucial role in the immune escape of tumor cells, proliferation, and formation of metastases) directly interacted with ENO1 and protected it from ubiquitin-mediated degradation, subsequently promoting glycolytic activity and progression of CRC [36]. The gene discussed is ENO1; the disease is neoplasm.